Summary:
- Accelus, a medical technology company based in Palm Beach Gardens, FL, secured growth equity funding led by Concord Health Partners.
- The funding will support the company’s commercial growth and the development of its innovative spinal implant technologies.
- Accelus specializes in expandable spinal implant technology designed to enhance surgical procedures and patient outcomes, with a product portfolio that includes the FlareHawk® Interbody Fusion System and LineSider Spinal System.
Rewritten Article:
Accelus Secures Growth Equity Funding for Advancement in Spinal Implant Technology
Accelus, a leading medical technology company located in Palm Beach Gardens, FL, has recently announced a successful round of growth equity funding. This funding, which was led by Concord Health Partners, will play a crucial role in supporting Accelus’ ongoing commercial growth initiatives and the further development of its groundbreaking spinal implant technologies.
Under the leadership of President and CEO Kevin McGann, Accelus is at the forefront of expandable spinal implant technology. Their focus lies in improving surgical procedures and enhancing patient outcomes through the introduction of innovative spinal solutions. One of their key technologies, Adaptive Geometry, is specifically tailored for transforaminal lumbar interbody fusion (TLIF), posterior lumbar interbody fusion (PLIF), endoscopic-assisted, percutaneous, and lateral spine surgeries.
Accelus boasts an impressive product portfolio that includes the FlareHawk® Interbody Fusion System, featuring Adaptive Geometry™ technology, the LineSider Spinal System with modular-cortical screws, and the Toro-L® Interbody Fusion System. With over 32,000 cages already implanted in 25 countries, Accelus continues to make a significant impact in the field of spinal implant technology.
This recent funding round signifies a new chapter of growth and innovation for Accelus, as they strive to revolutionize spinal surgeries and improve patient outcomes. Stay tuned for more updates on Accelus’ exciting developments in the medical technology sector.
